Exact Sciences to Webcast Presentation at Merrill Lynch 2005 Global Ph

    Business Editors/Health/Medical Writers
    Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and
    Medical Device Conference

    MARLBOROUGH, Mass.--(BUSINESS WIRE)--Feb. 7, 2005--EXACT Sciences Corporation (NASDAQ: EXAS) announced today that its presentation at the Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference will be webcast live.
    Don Hardison, EXACT Sciences' President and CEO, and Anthony Shuber, EXACT Sciences' Chief Technology Officer, are scheduled to deliver a presentation on Thursday, February 10, 2005 at 10:30 a.m. (Eastern Standard Time) at the Grand Hyatt Hotel in New York City. The presentation will discuss, among other things, the Company's applied research and commercial strategies, and the Company's focus of resources for 2005. The webcast of the presentation may be accessed at EXACT Sciences' website, www.exactsciences.com, through the Investor Relations page. An archived version of the webcast will be available for 14 days following the live presentation.

    About EXACT Sciences Corporation

    EXACT Sciences Corporation is a leader in rapidly applying genomics knowledge to develop effective, patient-friendly screening methods to detect cancer early, to assist physicians in saving patients' lives. Its first commercial test, PreGen-Plus(TM), is used for screening colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than 20 years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies will enable early detection of colorectal cancer so that more people can be effectively treated. Founded in 1995, EXACT Sciences is based in Marlborough, Mass. Detailed information on EXACT Sciences and PreGen-Plus can be found on the World Wide Web at www.exactsciences.com and www.pregenplus.com.

--30--LG/bo*

CONTACT: EXACT Sciences Amy Hedison, 508-683-1252 Investor Relations and Corporate Communications: ahedison@exactsciences.com or Fleishman-Hillard Kerry Beth Daly, 617-267-8223 dalyk@fleishman.com

KEYWORD: MASSACHUSETTS TRACK INDUSTRY KEYWORD: BANKING MEDICAL BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: EXACT Sciences

Copyright Business Wire 2005